PLX:NYSEAMERICAN
Protalix Biotherapeutics Inc
$2.71
arrow_upward
+0.37%(+0.0100) 1D
$2.71
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 5, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PLX...
Open
$2.68
High
$2.74
Low
$2.65
Mkt. cap
218.35M
Avg. vol.
766.33K
Volume
0.00
P/E ratio
11.98
52-wk high
$3.19
52-wk low
$1.60
EPS
$0.23
Beta
-0.09
Shares outstanding
80.57M
No. of employees
226
Open
$2.68
High
$2.74
Low
$2.65
Mkt. cap
218.35M
Avg. vol.
766.33K
Volume
0.00
P/E ratio
11.98
52-wk high
$3.19
52-wk low
$1.60
EPS
$0.23
Beta
-0.09
Shares outstanding
80.57M
No. of employees
226
News stories
From web sources and news partners
Simply Wall Street
·
12 minutes ago
Will Mood And Mind Drinks Change Walmart's (WMT) Narrative
Enidnews.com
·
1 hour ago
Everli, a Leading Italian E-Grocery Marketplace, Advances Toward Nasdaq Listing as SEC Declares Registration Statement Effective
CryptoRank
·
50 minutes ago
AGM Group raises $11M in private placement to bolster Nasdaq-listed balance sheet
Reuters
·
36 minutes ago
Wall Street profits soar to $45.9 billion in first half of 2026, report shows
Profile
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease. Wikipedia
About Protalix Biotherapeutics Inc
CEODror Bashan
Employees226
Founded1993
HeadquartersKarmiel, North District, Israel
SectorBiotechnology
Websiteprotalix.com